Literature DB >> 4511907

Survival in chronic myelogenous leukemia: influence of treatment and extent of disease at diagnosis.

S Monfardini, T Gee, J Fried, B Clarkson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4511907     DOI： 10.1002/1097-0142(197303)31:3<492::aid-cncr2820310302>3.0.co;2-4

Source DB:  PubMed          Journal:  Cancer        ISSN： 0008-543X            Impact factor:   6.860


× No keyword cloud information.
  5 in total

1.  Relationship of the duration of the chronic phase in chronic granulocytic leukaemia to the need for treatment during the first year after diagnosis.

Authors:  N J Wareham; S A Johnson; J M Goldman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

2.  Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disorders. A retrospective analysis of 260 patients.

Authors:  A Wehmeier; I Daum; H Jamin; W Schneider
Journal:  Ann Hematol       Date:  1991-08       Impact factor: 3.673

3.  Defective quorum sensing of acute lymphoblastic leukemic cells: evidence of collective behavior of leukemic populations as semi-autonomous aberrant ecosystems.

Authors:  Sapan J Patel; Su Dao; Costel C Darie; Bayard D Clarkson
Journal:  Am J Cancer Res       Date:  2016-06-01       Impact factor: 6.166

4.  Chemotherapy of autochthonous myeloid leukemias (Chloroleukemias) in Wistar rats.

Authors:  W J Zeller; K Reusch; D Schmähl
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

5.  Chronic granulocytic leukaemia: effect of elective splenectomy on the course of disease.

Authors:  A S Spiers; A F Baikie; D A Galton; H G Richards; E Wiltshaw; J M Goldman; D Catovsky; J Spencer; R Peto
Journal:  Br Med J       Date:  1975-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.